Changes to the guidance document on biosimilars

16 giugno 2023 – Swissmedic has revised the section on the interchangeability of biosimilars. Regarding content, it continues to be the case that minor differences as a result of manufacturing processes do not affect the safety and efficacy of the biosimilar compared to the reference product.

For more information, see here.